Seamus Mulligan, Director at Jazz Pharmaceuticals plc (JAZZ), bought 201,521 shares at $103.00 ($19.8M) on 2025-05-12, disclosed to the SEC on 2025-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.10 | 80,684 | $7.9M | 40.0% |
| 2 | $98.10 | 80,684 | $7.9M | 40.0% |
| 3 | $98.91 | 19,216 | $1.9M | 9.6% |
| 4 | $98.91 | 19,216 | $1.9M | 9.6% |
| 5 | $99.71 | 100 | $10K | 0.1% |
| 6 | $103.00 | 1,621 |
| $167K |
| 0.8% |
| Total | $98.29 avg | 201,521 | $19.8M | 100% |
| Filing → |
| JAZZ | SELL | 2016-08-26 | $6.0M | — | Filing → |
| JAZZ | SELL | 2016-05-26 | $8.2M | — | Filing → |
| JAZZ | SELL | 2016-02-24 | $6.9M | — | Filing → |